Research funding for chronic fatigue syndrome (ME/CFS) has been poor at best but clinical trials have elicited a wholly different degree of disappointment altogether. Few clinical trials are ever done and those often involve alternative approaches. The six active...
Two Cognitive Diseases Fibromyalgia is more than a pain disease – it’s also a cognitive disease. In fact, some studies suggest the cognitive issues can present more problems than the pain. They’ve been prevalent and serious enough to spark the...
The FDA is clamping down harder and harder on opioid drugs, but it’s the Justice Department that’s probably sending the chills up some doctors’ spines. The Justice Department’s Opioid Fraud and Abuse Detection Unit, which operates in 12...
Patient “X” was living high when he got ill. A course creator and director for an enterprise delivering transformational experiences, X thrived on his 100-hour work weeks. From the U.S. to lndia to Australia to Germany, he made his living making a difference with...
Difference-Maker Unlike FMS, SFPN has identifiable pathology, physiology, and causes, and thus is definitionally a disease. Oaklander et. Al. Dr. Anne Oaklander MD, PhD, is making a difference – maybe a very big difference in the lives of many. Making a...
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.